Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management.

Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. Abstract Text:

    alan b tuckAlan B Tuck,ann f chambersAnn F Chambers,alison l allanAlison L Allan,

    Osteopontin (OPN) is a secreted protein that is overexpressed in a number of human cancers, and has been associated with increased metastatic burden and poor prognosis in breast cancer patients. The OPN protein contains several conserved structural elements including heparin- and calcium-binding domains, a thrombin-cleavage site, a CD44 binding site, and two integrin-binding sites. Experimental studies have shown that the ability of OPN to interact with a diverse range of factors, including cell surface receptors (integrins, CD44), secreted proteases (matrix metalloproteinases, urokinase plasminogen activator), and growth factor/receptor pathways (TGFalpha/EGFR, HGF/Met) is central to its role in malignancy. These complex signaling interactions can result in changes in gene expression, which ultimately lead to alterations in cell properties involved in malignancy such as adhesion, migration, invasion, enhanced tumor cell survival, tumor angiogenesis, and metastasis. Therefore, OPN is not merely associated with cancer, but rather it plays a multi-faceted functional role via complex molecular cross-talk with other factors. This review will focus on the role of OPN in breast cancer, in particular on the malignancy-promoting aspects of OPN that may reveal opportunities for new approaches to the clinical management of breast cancer.

    Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. Publishing Authors By Initials

    ab tuckAB Tuck,af chambersAF Chambers,al allanAL Allan,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of cellular biochemistry

    VOLUME: 102

    Page Numbers: 859-68

    Journal Abbreviation: J. Cell. Biochem.

    ISSN: 0730-2312

    DAY: 1

    MONTH: Nov

    YEAR: 2007

    Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8205768

    Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management.

    AFFILIATION: London Regional Cancer Program, London Health Sciences Centre, London, Ontario, Canada. atuck@uwo.ca

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Cell Biochem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News